Literature DB >> 24008553

Does breast cancer screening level health inequalities out? A population-based study in an Italian region.

Barbara Pacelli1, Elisa Carretta, Teresa Spadea, Nicola Caranci, Enza Di Felice, Elisa Stivanello, Silvio Cavuto, Luca Cisbani, Silvia Candela, Rossana De Palma, Maria P Fantini.   

Abstract

BACKGROUND: Although population-based screening has the potential to reduce inequalities in breast cancer survival, evidence on this topic is controversial. The objective of this study was to evaluate whether the full implementation of a mammography screening programme in Emilia-Romagna in Italy had an impact on variations in breast cancer survival by educational level.
METHODS: A cohort study was performed, including all women <70 years and residing in Emilia-Romagna who had infiltrating breast cancer registered in 1997-2000 (transitional screening period) or 2001-03 (consolidation screening period). Cancer cases were retrieved from the regional Breast Cancer Registry and followed up for 5 years. Educational level was determined from census data and allocated to cancer cases by individual record linkage. Age at diagnosis was classified into two groups (30-49, 50-69: screening target population).
RESULTS: A total of 9639 cases were analyzed. In the 1997-2000 period, low-educated women had significantly lower survival compared with high-educated women, both in the younger and in the older age-groups. After the full implementation of the screening programme, these differences decreased in both age-groups, until disappearing completely among women in the age-group invited to screening.
CONCLUSIONS: Our findings suggest that a fee-free population-based organized mammography screening programme with active invitation of the whole target population could be effective in reducing differences in survival in the population targeted by the screening.

Entities:  

Mesh:

Year:  2013        PMID: 24008553     DOI: 10.1093/eurpub/ckt119

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  10 in total

1.  Impact of deprivation on breast cancer survival among women eligible for mammographic screening in the West Midlands (UK) and New South Wales (Australia): Women diagnosed 1997-2006.

Authors:  Laura M Woods; Bernard Rachet; Dianne O'Connell; Gill Lawrence; Michel P Coleman
Journal:  Int J Cancer       Date:  2016-02-13       Impact factor: 7.396

2.  Influence of adherence with guideline-driven recommendations on survival in women operated for breast cancer: Real-life evidence from Italy.

Authors:  Giovanni Corrao; Federico Rea; Enza Di Felice; Mirko Di Martino; Marina Davoli; Luca Merlino; Flavia Carle; Rossana De Palma
Journal:  Breast       Date:  2020-07-01       Impact factor: 4.380

3.  Geographical and socioeconomic differences in uptake of Pap test and mammography in Italy: results from the National Health Interview Survey.

Authors:  Alessio Petrelli; Paolo Giorgi Rossi; Lisa Francovich; Barbara Giordani; Anteo Di Napoli; Marco Zappa; Concetta Mirisola; Lidia Gargiulo
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

4.  Socio-economic inequality of utilization of cancer testing in Europe: A cross-sectional study.

Authors:  H Bozhar; M McKee; T Spadea; P Veerus; S Heinävaara; A Anttila; C Senore; N Zielonke; I M C M de Kok; N T van Ravesteyn; I Lansdorp-Vogelaar; H J de Koning; E A M Heijnsdijk
Journal:  Prev Med Rep       Date:  2022-02-08

5.  Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy.

Authors:  Luigi Grassi; Elisa Stivanello; Martino Belvederi Murri; Vincenza Perlangeli; Paolo Pandolfi; Fabio Carnevali; Rosangela Caruso; Alessio Saponaro; Mila Ferri; Michele Sanza; Angelo Fioritti; Elena Meggiolaro; Federica Ruffilli; Maria Giulia Nanni; Maria Ferrara; Paola Carozza; Luigi Zerbinati; Tommaso Toffanin; Marco Menchetti; Domenico Berardi
Journal:  Psychooncology       Date:  2021-09-09       Impact factor: 3.955

6.  Economic evaluation of the breast cancer screening programme in the Basque Country: retrospective cost-effectiveness and budget impact analysis.

Authors:  Arantzazu Arrospide; Montserrat Rue; Nicolien T van Ravesteyn; Merce Comas; Myriam Soto-Gordoa; Garbiñe Sarriugarte; Javier Mar
Journal:  BMC Cancer       Date:  2016-06-01       Impact factor: 4.430

7.  Socioeconomic deprivation worsens the outcomes of Italian women with hormone receptor-positive breast cancer and decreases the possibility of receiving standard care.

Authors:  Francesca Di Salvo; Nicola Caranci; Teresa Spadea; Nicolas Zengarini; Pamela Minicozzi; Hade Amash; Mario Fusco; Fabrizio Stracci; Fabio Falcini; Claudia Cirilli; Giuseppina Candela; Rosanna Cusimano; Rosario Tumino; Milena Sant
Journal:  Oncotarget       Date:  2017-07-22

8.  Geographic Inequalities in Breast Cancer in Italy: Trend Analysis of Mortality and Risk Factors.

Authors:  Paolo Giorgi Rossi; Olivera Djuric; Simone Navarra; Alessandra Rossi; Anteo Di Napoli; Luisa Frova; Alessio Petrelli
Journal:  Int J Environ Res Public Health       Date:  2020-06-11       Impact factor: 3.390

9.  Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy.

Authors:  Roberto Gnavi; Veronica Sciannameo; Francesca Baratta; Cecilia Scarinzi; Marco Parente; Massimo Mana; Mario Giaccone; Paolo Cavallo Perin; Giuseppe Costa; Teresa Spadea; Paola Brusa
Journal:  PLoS One       Date:  2020-03-18       Impact factor: 3.240

10.  Early detection of breast cancer rectifies inequality of breast cancer outcomes.

Authors:  László Tabár; Tony Hsiu-Hsi Chen; Amy Ming-Fang Yen; Peter B Dean; Robert A Smith; Håkan Jonsson; Sven Törnberg; Sam Li-Sheng Chen; Sherry Yueh-Hsia Chiu; Jean Ching-Yuan Fann; May Mei-Sheng Ku; Wendy Yi-Ying Wu; Chen-Yang Hsu; Yu-Ching Chen; Gunilla Svane; Edward Azavedo; Helene Grundström; Per Sundén; Karin Leifland; Ewa Frodis; Joakim Ramos; Birgitta Epstein; Anders Åkerlund; Ann Sundbom; Pál Bordás; Hans Wallin; Leena Starck; Annika Björkgren; Stina Carlson; Irma Fredriksson; Johan Ahlgren; Daniel Öhman; Lars Holmberg; Stephen W Duffy
Journal:  J Med Screen       Date:  2020-05-05       Impact factor: 2.136

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.